Skip to main content
. 2015 May 19;6(7):736–740. doi: 10.1021/acsmedchemlett.5b00117

Figure 1.

Figure 1

Lead progression: iv POC (1), oral POC (2), and clinical candidate (3). (The “magic methyl” groups are shown in red.)